bpc-157 oral vs injection dosing Peptide Oral: Which Route Actually Works? BPC-157 Injection vs Oral Peptide:

But they have their fair share of cons

Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice

By limiting prolonged inflammation, it may reduce secondary tissue damage and support a controlled healing environment

This mechanism is also the source of cancer-related concerns (more below)

But honestly, the short answer doesn't do justice to the science behind it or the potential consequences of getting it wrong